Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-21 6:32 pm Sale | 2026-08-19 | 13D | VERADERMICS INC MANE | Montanova Capital, LLC | 3,718,970 8.800% | -453,151 (-10.86%) | Filing History |
| 2026-08-14 4:25 pm Sale | 2026-06-30 | 13G | ABEONA THERAPEUTICS INC NE ABEO | Montanova Capital, LLC | 500,000 0.900% | -2,176,000 (-81.32%) | Filing History |
| 2026-08-14 4:24 pm Purchase | 2026-06-30 | 13G | KURA ONCOLOGY INC KURA | Montanova Capital, LLC | 8,575,422 9.700% | 1,014,422 (+13.42%) | Filing History |
| 2026-08-14 4:23 pm Purchase | 2026-06-30 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Montanova Capital, LLC | 3,549,539 4.200% | 189,539 (+5.64%) | Filing History |
| 2026-08-14 4:22 pm Sale | 2026-06-30 | 13G | FULCRUM THERAPEUTICS INC FULC | Montanova Capital, LLC | 3,680,921 5.500% | -1,386,473 (-27.36%) | Filing History |
| 2026-08-14 4:21 pm Purchase | 2026-06-30 | 13G | INFLARX N V COM IFRX | Montanova Capital, LLC | 22,933,910 15.600% | 15,000,000 (+189.06%) | Filing History |
| 2026-08-06 5:48 pm Purchase | 2026-07-30 | 13G | REPLIMUNE GROUP INC REPL | Montanova Capital, LLC | 6,609,000 7.900% | 2,387,164 (+56.54%) | Filing History |
| 2026-06-23 4:35 pm Purchase | 2026-06-15 | 13G | FAETH THERAPEUTICS INC FTH | Montanova Capital, LLC | 2,020,103 7.800% | 2,020,103 (New Position) | Filing History |
| 2026-05-12 6:32 pm Purchase | 2026-03-31 | 13G | REPLIMUNE GROUP INC REPL | Montanova Capital, LLC | 4,221,836 5.100% | 4,221,836 (New Position) | Filing History |
| 2026-05-12 6:24 pm Sale | 2026-03-31 | 13G | ERASCA INC ERAS | Montanova Capital, LLC | 3,434,967 1.100% | -11,067,037 (-76.31%) | Filing History |
| 2026-05-12 6:15 pm Purchase | 2026-03-31 | 13G | ZURA BIO LTD ZURA | Montanova Capital, LLC | 9,524,263 9.900% | 3,957,262 (+71.08%) | Filing History |
| 2026-05-08 6:52 pm Purchase | 2026-05-01 | 13D | AVALYN PHARMA INC AVLN | Montanova Capital, LLC | 2,503,109 5.600% | 2,503,109 (New Position) | Filing History |
| 2026-05-05 9:39 pm Purchase | 2026-05-01 | 13D | VERADERMICS INC MANE | Montanova Capital, LLC | 4,172,121 9.900% | 3,130 (+0.08%) | Filing History |
| 2026-04-13 5:03 pm Purchase | 2026-04-06 | 13G | LEXEO THERAPEUTICS INC LXEO | Montanova Capital, LLC | 5,674,778 7.700% | 5,674,778 (New Position) | Filing History |
| 2026-02-26 7:10 pm Purchase | 2026-02-19 | 13G | CAPRICOR THERAPEUTICS INC CAPR | Montanova Capital, LLC | 3,417,891 6.600% | 3,417,891 (New Position) | Filing History |
| 2026-02-13 4:50 pm Unchanged | 2025-12-31 | 13G | SUTRO BIOPHARMA INC STRO | Montanova Capital, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-02-13 4:49 pm Sale | 2025-12-31 | 13G | SUTRO BIOPHARMA INC STRO | Montanova Capital, LLC | 0 0.000% | -648,832 (Position Closed) | Filing History |
| 2026-02-13 4:46 pm Purchase | 2025-12-31 | 13G | ZURA BIO LTD ZURA | Montanova Capital, LLC | 5,567,001 8.600% | 706,062 (+14.53%) | Filing History |
| 2026-02-13 4:41 pm Sale | 2025-12-31 | 13G | IMMATICS N V IMTX | Montanova Capital, LLC | 11,190,129 8.300% | -840,000 (-6.98%) | Filing History |
| 2026-02-13 4:32 pm Purchase | 2025-12-31 | 13G | INFLARX N V COM IFRX | Montanova Capital, LLC | 7,933,910 11.700% | 2,200,000 (+38.37%) | Filing History |